Press Release: Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024
Baird Downgrades Edwards Lifesciences(EW.US) to Hold Rating, Cuts Target Price to $73
Edwards Lifesciences Insider Sold Shares Worth $347,534, According to a Recent SEC Filing
Edwards Lifesciences to Report Q3 Earnings: What's in the Cards?
Express News | Edwards Lifesciences Corp : Mizuho Cuts Target Price to $78 From $85
Analysts Conflicted on These Healthcare Names: Allakos (ALLK), Edwards Lifesciences (EW) and NewAmsterdam Pharma Company (NAMS)
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}